We serve Chemical Name:[5-(4-methoxyphenyl)-1,2-oxazol-3-yl]methanol CAS:58492-77-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:[5-(4-methoxyphenyl)-1,2-oxazol-3-yl]methanol
CAS.NO:58492-77-6
Synonyms:(5-(4-methoxyphenyl)isoxazol-3-yl)methanol;f2135-0535
Molecular Formula:C11H11NO3
Molecular Weight:205.21000
HS Code:2934999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:55.49000
Exact Mass:205.07400
LogP:1.84250
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (5-(4-methoxyphenyl)isoxazol-3-yl)methanol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,f2135-0535 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,f2135-0535 Use and application,(5-(4-methoxyphenyl)isoxazol-3-yl)methanol technical grade,usp/ep/jp grade.
Related News: Today’s decisions represent progress in our continued efforts to make a difference in this pandemic on a global scale, Kathy Wengel, J&J’s chief global supply chain officer, said in the statement. [5-(4-methoxyphenyl)-1,2-oxazol-3-yl]methanol manufacturer Today’s decisions represent progress in our continued efforts to make a difference in this pandemic on a global scale, Kathy Wengel, J&J’s chief global supply chain officer, said in the statement. [5-(4-methoxyphenyl)-1,2-oxazol-3-yl]methanol supplier The workers are demanding that Hong Kong close all border checkpoints to visitors from mainland China, saying they represent a threat to health care workers in the city. [5-(4-methoxyphenyl)-1,2-oxazol-3-yl]methanol vendor The program will run alongside our ongoing Phase 3 INSPIRE Trial, and is expected to continue until commercial launch in such countries. [5-(4-methoxyphenyl)-1,2-oxazol-3-yl]methanol factory Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business.